Relationship between autonomic cardiac activity, beta-cell function, anthropometrics and metabolic indices in type II diabetics

Clin Endocrinol (Oxf). 2002 Aug;57(2):259-64. doi: 10.1046/j.1365-2265.2002.01596.x.


Objective: Recent studies have demonstrated that C-peptide exerts beneficial effects on the diabetic state, including improvements in kidney and nerve function. Thus, we investigated the effect of residual pancreatic C-peptide secretion on the cardiac autonomic nervous system in well- and poorly controlled type II diabetic patients.

Design: Randomised cross-sectional study.

Patients: Forty type II diabetic patients free from diabetic neuropathy, with similar anthropometric parameters, volunteered for our study.

Measurements: Insulin action, residual pancreatic C-peptide secretion and the cardiac autonomic nervous system were investigated by euglycaemic hyperinsulinaemic clamp, glucagon bolus test and heart rate variability, respectively. M-values were used as an index of insulin sensitivity. High frequency (HF) and low frequency (LF) oscillations in heart rate were analysed.

Results: The patients were categorized into those with good (HbA1c < or = 7.0) and poor (HbA1c > or = 8.0) metabolic control. The patients with good metabolic control had fasting plasma glucose and C-peptide levels, plasma area under the curve (auc) insulin and C-peptide levels, M-values, LF values and LF/HF ratio significantly lower than patients with poor metabolic control. In contrast, RR interval, total power and HF values had an opposite trend. Basal plasma C-peptide correlated with LF/HF in patients with good (r = -0.42; P < 0.05) and poor metabolic control (r = -0.45; P < 0.05). An even stronger correlation between auc C-peptide and LF/HF in patients with good (r = -0.53, P < 0.002) and poor metabolic control (r = -0.49; P < 0.03), as well as in the whole group (r = -0.83; P < 0.001) was found. By multiple regression analyses performed in all patients, LF/HF were independently associated with auc C-peptide (t = -8.618; P < 0.001) but not basal C-peptide levels (t = -0.137; P < 0.88).

Conclusion: Our study demonstrated that preserved C-peptide secretion is associated with a well balanced cardiac autonomic activity in type II diabetic patients.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Area Under Curve
  • Autonomic Nervous System / physiopathology*
  • Blood Glucose / analysis
  • C-Peptide / metabolism*
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Electrocardiography, Ambulatory
  • Female
  • Heart Conduction System / physiopathology*
  • Humans
  • Islets of Langerhans / metabolism*
  • Islets of Langerhans / physiopathology
  • Male
  • Middle Aged


  • Blood Glucose
  • C-Peptide